PRNewswire

SAN DIEGO, Oct. 9, 2024 /PRNewswire/ — DermTech, LLC (DermTech) a leader in precision dermatology offering non-invasive skin genomics solutions, announced the publication of new data suggesting that non-invasive genomic testing can reliably differentiate melanoma in situ from morphologically

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: